• Citer

A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer

par Zhang, Zhenyang;Xie, Shuhan;Cai, Weijing;Hong, Zhi Nuan;Yang, Chuangcai;Lin, Yukang;Zhu, Jiafu;Lin, Zhiwei;Christoph, Daniel Christian;Bohnenberger, Hanibal;Kepka, Lucyna;Brueckl, Wolfgang Michael;Van Houtte, Paul ;Kang, Mingqiang;Lin, Jiangbo
Référence Translational lung cancer research, 11, 1, page (75-86)
Publication Publié, 2022-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer
Auteur:	Zhang, Zhenyang; Xie, Shuhan; Cai, Weijing; Hong, Zhi Nuan; Yang, Chuangcai; Lin, Yukang; Zhu, Jiafu; Lin, Zhiwei; Christoph, Daniel Christian; Bohnenberger, Hanibal; Kepka, Lucyna; Brueckl, Wolfgang Michael; Van Houtte, Paul; Kang, Mingqiang; Lin, Jiangbo
Informations sur la publication:	Translational lung cancer research, 11, 1, page (75-86)
Statut de publication:	Publié, 2022-01
Sujet CREF:	Cancérologie
Mots-clés:	Adjuvant chemotherapy
	Nomogram for risk of recurrence
	Non-small cell lung cancer (NSCLC)
	Stage IB
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2218-6751
	info:doi/10.21037/tlcr-21-1038
	info:scp/85123737900